Lida María Rodas Marín

Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy

David H Adams, Jonas Wixner, Michael J. Polydefkis, John L. Berk et autres

Importance: There is a lack of long-term efficacy and safety data on hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) and on RNA interference (RNAi) therapeutics in general. This study presents the longest-term data to date on patisiran for hATTR-PN. Objective: To present the …

fr, se, us, pt, jp (code pays fourni par la source)

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, Charles E. Alpers et autres

us, gb, nl, au, kr, de, it, be, pl, br, es, hk, cz, ar (code pays fourni par la source)

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, Jonathan Barratt et autres

nl, au, us, gb, br, ar (code pays fourni par la source)

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David H Adams, Michael J. Polydefkis, Alejandra González‐Duarte, Jonas Wixner et autres

fr, us, mx, se, de, es, pt, gb, cy, br, ca, jp (code pays fourni par la source)

SP184CLINICAL IMPLICATIONS AND PATHOLOGICAL CLASSIFICATION OF TUBULOINTERSTITIAL INJURY FOR THE PREDICTION OF RENAL OUTCOME IN LUPUS NEPHRITIS

Lida María Rodas Marín, Claudia Mardones, Manuel Ferreira Gomes, Adriana García‐Herrera et autres

INTRODUCTION AND AIMS: Tubulointerstitial lesions are a common finding in Lupus Nephritis (LN) and impacts in renal outcome independently of glomerular lesions,however the current classification does not include a mandatory score of this kind of injury and there is scarce information about …

es (code pays fourni par la source)

Dos métodos de anticoagulación en técnicas continuas de depuración extrarrenal

Sergi Aragó Sorrosal, Lida María Rodas Marín, Ferràn Torres, Vanesa Villegas Jiménez et autres

Introduction: Continuous extra-renal depuration techniques are the therapy of choice in critically ill patients. But, they are not exempt from complications such as the coagulation of the extracorporeal circuit. The drug traditionally used for anticoagulation is sodium heparin. Although other methods of …

es, br (code pays fourni par la source)

MP306EFFICACY AND SAFETY OF REGIONAL CITRATE ANTICOAGULATION IN CONTINUOUS HEMODIAFILTRATION IN CLINICAL PRACTICE

María Huguet Mas, Lida María Rodas Marín, Miquel Blasco Pelícano, Luis Fernando Quintana Porras et autres

INTRODUCTION AND AIMS: Heparin is the most common method of anticoagulation in continuous renal replacement therapy (CRRT). Regional citrate anticoagulation (RCA) is being increasingly used as an alternative due to advantages concerning prolonged filter lifetime and no-systemic anticoagulation. Despite this, metabolic side-effects …

es (code pays fourni par la source)

Técnicas continuas de depuración extrarrenal: dos métodos de anticoagulación

Sergi Aragó Sorrosal, Lida María Rodas Marín, Ferràn Torres, Vanesa Villegas Jiménez

DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.